Overview
Plague is a severe and potentially life-threatening infectious disease caused by the bacterium Yersinia pestis. It is not a genetic disorder but rather a zoonotic infection transmitted primarily through the bites of infected fleas that live on rodents, or through direct contact with infected animals or respiratory droplets from infected individuals. Plague is classified as a rare disease due to its low incidence in most parts of the world, though sporadic outbreaks continue to occur, particularly in parts of Africa, Asia, and the Americas. Plague manifests in three primary clinical forms. Bubonic plague (ICD-10: A20.0), the most common form, is characterized by painful, swollen lymph nodes called buboes, typically in the groin, axilla, or cervical region, accompanied by sudden onset of high fever, chills, headache, and severe malaise. Septicemic plague (A20.1) occurs when the bacteria spread to the bloodstream, causing disseminated intravascular coagulation, septic shock, and potentially gangrene of the extremities — historically giving rise to the name "Black Death." Pneumonic plague (A20.2) affects the lungs and is the most dangerous form, as it can be transmitted person-to-person via respiratory droplets and progresses rapidly to respiratory failure if untreated. Other forms include plague meningitis (A20.3) and pharyngeal plague. Without treatment, plague has a very high mortality rate, particularly for pneumonic and septicemic forms. However, early diagnosis and prompt antibiotic therapy dramatically improve outcomes. First-line treatments include streptomycin, gentamicin, doxycycline, and ciprofloxacin. Supportive care in an intensive care setting may be required for severe cases. Public health measures including flea control, rodent management, surveillance, and prophylactic antibiotics for exposed contacts are critical in outbreak settings. No widely available vaccine is currently in routine clinical use, though research into plague vaccines continues.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
4 eventsInstitute of Tropical Medicine, Belgium
Dynavax Technologies Corporation — PHASE2
Just-Evotec Biologics — PHASE1
Kaohsiung Medical University Chung-Ho Memorial Hospital — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Plague.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesRebyota
Ferring
C. diff infection
VOWST
Seres Therapeutics, Inc.
C. diff Infection
Travel Grants
No travel grants are currently matched to Plague.
Community
No community posts yet. Be the first to share your experience with Plague.
Start the conversation →Latest news about Plague
Disease timeline:
New recruiting trial: The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal Disease
A new clinical trial is recruiting patients for Plague
New recruiting trial: Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
A new clinical trial is recruiting patients for Plague
New recruiting trial: Modifying PEST for Psoriatic Arthritis Screening
A new clinical trial is recruiting patients for Plague
New recruiting trial: Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults
A new clinical trial is recruiting patients for Plague
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Plague
What is Plague?
Plague is a severe and potentially life-threatening infectious disease caused by the bacterium Yersinia pestis. It is not a genetic disorder but rather a zoonotic infection transmitted primarily through the bites of infected fleas that live on rodents, or through direct contact with infected animals or respiratory droplets from infected individuals. Plague is classified as a rare disease due to its low incidence in most parts of the world, though sporadic outbreaks continue to occur, particularly in parts of Africa, Asia, and the Americas. Plague manifests in three primary clinical forms. Bub
Are there clinical trials for Plague?
Yes — 3 recruiting clinical trials are currently listed for Plague on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Plague?
25 specialists and care centers treating Plague are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Plague?
2 patient support programs are currently tracked on UniteRare for Plague. See the treatments and support programs sections for copay assistance, eligibility, and contact details.